Rachael L. BRAKE

Person

Natick, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating gastrointestinal immune-related adverse events...
- Patent number 11,760,803
- Issue date Sep 19, 2023
- Takeda Pharmaceutical Company Limited
- Rachael L. Brake
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations of a pan-RAF kinase inhibitor and proce...
- Patent number 10,426,782
- Issue date Oct 1, 2019
- Millennium Pharmaceuticals, Inc.
- Rachael L. Brake
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination of catalytic mTORC1/2 inhibitors and selective inhibito...
- Patent number 9,724,354
- Issue date Aug 8, 2017
- Millennium Pharmaceuticals, Inc.
- Rachael L. Brake
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF TREATING GASTROINTESTINAL IMMUNE-RELATED ADVERSE EVENTS...
- Publication number 20240247067
- Publication date Jul 25, 2024
- Takeda Pharmaceutical Company Limited
- Rachael L. BRAKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF RAF INHIBITORS AND TAXANES
- Publication number 20200316067
- Publication date Oct 8, 2020
- DOT Therapeutics-1, Inc.
- Viviana Bozon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF SPLEEN TYROSINE KINASE INHIBITORS AND OTHER THERAPEU...
- Publication number 20190231757
- Publication date Aug 1, 2019
- Takeda Pharmaceutical Company Limited
- Rachael L. Brake
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF RAF INHIBITORS AND TAXANES
- Publication number 20190117652
- Publication date Apr 25, 2019
- Millennium Pharmaceuticals, Inc.
- Viviana BOZON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING GASTROINTESTINAL IMMUNE-RELATED ADVERSE EVENTS...
- Publication number 20190040140
- Publication date Feb 7, 2019
- Millennium Pharmaceuticals, Inc.
- Rachael L. Brake
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBIT...
- Publication number 20180117060
- Publication date May 3, 2018
- Millennium Pharmaceuticals, Inc.
- Rachael L. BRAKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY
- Publication number 20180066068
- Publication date Mar 8, 2018
- Millennium Pharmaceuticals, Inc.
- Rachael L. BRAKE
- G01 - MEASURING TESTING
Information Patent Application
PHARMACEUTICAL FORMULATIONS OF A PAN-RAF KINASE INHIBITOR, PROCESSE...
- Publication number 20170173033
- Publication date Jun 22, 2017
- MILLENNIUM PHARMACEUTICALS,INC.
- Rachael L. BRAKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY
- Publication number 20170037151
- Publication date Feb 9, 2017
- Millennium Pharmaceuticals, Inc.
- Rachael L. BRAKE
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBIT...
- Publication number 20160271140
- Publication date Sep 22, 2016
- Millennium Pharmaceuticals, Inc.
- Rachael L. BRAKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Rachael L. BRAKE

Person

Patents Grantslast 30 patents

Methods of treating gastrointestinal immune-related adverse events...

Pharmaceutical formulations of a pan-RAF kinase inhibitor and proce...

Combination of catalytic mTORC1/2 inhibitors and selective inhibito...

Patents Applicationslast 30 patents

METHODS OF TREATING GASTROINTESTINAL IMMUNE-RELATED ADVERSE EVENTS...

COMBINATION OF RAF INHIBITORS AND TAXANES

COMBINATION OF SPLEEN TYROSINE KINASE INHIBITORS AND OTHER THERAPEU...

COMBINATION OF RAF INHIBITORS AND TAXANES

METHODS OF TREATING GASTROINTESTINAL IMMUNE-RELATED ADVERSE EVENTS...

COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBIT...

ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY

PHARMACEUTICAL FORMULATIONS OF A PAN-RAF KINASE INHIBITOR, PROCESSE...

ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY

COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBIT...